DK2958935T3 - Vaccine - Google Patents

Vaccine Download PDF

Info

Publication number
DK2958935T3
DK2958935T3 DK14711297.3T DK14711297T DK2958935T3 DK 2958935 T3 DK2958935 T3 DK 2958935T3 DK 14711297 T DK14711297 T DK 14711297T DK 2958935 T3 DK2958935 T3 DK 2958935T3
Authority
DK
Denmark
Prior art keywords
vaccine
Prior art date
Application number
DK14711297.3T
Other languages
English (en)
Inventor
John Clements
Weiping Zhang
Halvor Sommerfelt
James P Nataro
Pål Puntervoll
Arne M Taxt
Original Assignee
Bergen Teknologioverforing As
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bergen Teknologioverforing As, The Administrators Of The Tulane Educational Fund filed Critical Bergen Teknologioverforing As
Application granted granted Critical
Publication of DK2958935T3 publication Critical patent/DK2958935T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK14711297.3T 2013-02-20 2014-02-20 Vaccine DK2958935T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361766958P 2013-02-20 2013-02-20
US201361850636P 2013-02-20 2013-02-20
US201361767161P 2013-02-20 2013-02-20
US201361886242P 2013-10-03 2013-10-03
PCT/IB2014/000267 WO2014128555A2 (en) 2013-02-20 2014-02-20 Vaccine

Publications (1)

Publication Number Publication Date
DK2958935T3 true DK2958935T3 (da) 2019-09-16

Family

ID=50336353

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14711297.3T DK2958935T3 (da) 2013-02-20 2014-02-20 Vaccine

Country Status (8)

Country Link
US (1) US10166279B2 (da)
EP (1) EP2958935B1 (da)
CN (1) CN105658661B (da)
DK (1) DK2958935T3 (da)
ES (1) ES2743431T3 (da)
HK (1) HK1217206A1 (da)
PL (1) PL2958935T3 (da)
WO (1) WO2014128555A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014008406A2 (en) 2012-07-05 2014-01-09 Children's Medical Center Corporation The bacterial biofilm matrix as a platform for protein delivery
US11071779B2 (en) 2016-06-17 2021-07-27 Children's Medical Center Corporation Biofilm matrix-boosted vaccine
CN106442988B (zh) * 2016-10-08 2018-03-20 扬州大学 产肠毒素大肠杆菌etec f4菌毛直接受体蛋白猪氨肽酶n功能结合域
CN113195520A (zh) * 2018-08-24 2021-07-30 挪威西部创新股份有限公司 作为抗腹泻疫苗抗原的热稳定肠毒素突变体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987237A (en) 1983-08-26 1991-01-22 Ribi Immunochem Research, Inc. Derivatives of monophosphoryl lipid A
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9717652D0 (en) * 1997-08-20 1997-10-22 Nycomed Imaging As Method
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2010048322A1 (en) * 2008-10-21 2010-04-29 Emergent Product Development United Kingdom Use of e. coli surface antigen 3 sequences for the export of heterologous antigens

Also Published As

Publication number Publication date
CN105658661A (zh) 2016-06-08
HK1217206A1 (zh) 2016-12-30
WO2014128555A3 (en) 2015-02-26
US10166279B2 (en) 2019-01-01
WO2014128555A2 (en) 2014-08-28
ES2743431T3 (es) 2020-02-19
CN105658661B (zh) 2020-07-24
US20160220654A1 (en) 2016-08-04
EP2958935B1 (en) 2019-07-03
EP2958935A2 (en) 2015-12-30
PL2958935T3 (pl) 2020-03-31

Similar Documents

Publication Publication Date Title
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
DK3077047T3 (da) Aramcholsalte
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T5 (da) Bindestrimler
DK3052081T3 (da) Pastil
DK2946640T3 (da) Langmuir-probe
DK3071227T3 (da) Fiskevaccine
DE102013106534B8 (de) Chromatographiepipettenspitze
DK2958935T3 (da) Vaccine
DE112014001252A5 (de) Aufbissschiene
DK2981168T3 (da) Laminitiskile
DK3086679T3 (da) Sportssko
FI10343U1 (fi) Mittateippi
FI10138U1 (fi) Kelkkateltta
ES1078715Y (es) Mosquitera
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
FI10396U1 (fi) Tielana
FI10399U1 (fi) Klapivaste
ES1100380Y (es) Trompo
ES1093505Y (es) Aerociclo
ES1096481Y (es) Ecofregona
ES1093455Y (es) Columbario